×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 8 Track 2: Business Benefits and Insights Gained from Regulatory Intelligent Automation Implementations
Session Chair(s)
Cary Smithson, MBA
Senior Director, Business Transformation & Systems Management
Cencora Pharmalex, United States
Session 8 Track 2: Business Benefits and Insights Gained from Regulatory Intelligent Automation Implementations
Learning Objective : - Identify how sponsor companies are reaping value from their intelligent automation initiatives in Regulatory
- Differentiate between use cases that provide greater value from those that are not worth pursuing
- Discuss approaches for implementing and scaling IA technologies and how to deal with challenges along the way
- Propose ways sponsor companies can influence vendors collectively
Speaker(s)
Panelist
Catalina Rojas Fallas, PharmD, MSc
F. Hoffmann-La Roche Ltd, Switzerland
International Regulatory Team Lead
Panelist
Francis Quinn
Pfizer, Inc., United States
Regional Director, AMER Publishing
Panelist
Chris Whalley
Pfizer Inc, United States
Senior Director and Head of Global Regulatory Intelligence
Have an account?